 |
|
Impact of Recommendations to Suspend the Birth Dose of Hepatitis B Virus Vaccine
Ronda J. Oram, MD;
Robert S. Daum, MD;
John B. Seal, MA;
Diane S. Lauderdale, PhD
JAMA. 2001;285:1874-1879.
Context In July 1999, due to concerns about thimerosal content, the American Academy of Pediatrics (AAP) and the Public Health Service (PHS) recommended suspending hepatitis B virus (HBV) vaccination at birth except for mothers who had positive or unknown hepatitis B surface antigen (HBsAg) status. In September 1999, the Centers for Disease Control and Prevention recommended that hospitals resume HBV vaccination at birth with a new thimerosal-free vaccine. Whether the 2 changes in recommendations within 3 months led to less-than-optimal compliance in hospital nurseries is unknown.
Objective To determine hospital HBV vaccination policy before the recommendation for delay of HBV vaccination and 1 year later.
Design, Setting, and Participants Survey of all 46 hospitals with obstetric services and neonatal nurseries in Cook County, Illinois.
Main Outcome Measures Hepatitis B virus immunization practices before July 1999 and in August 2000; hospital factors associated with routine HBV immunization and compliance with AAP and PHS recommendations.
Results Before July 1999, 74% of surveyed hospital nurseries offered HBV vaccine to all neonates; only 39% did so in August 2000. Being located in the Chicago city limits (88% vs 57%; P = .02) and having an academic affiliation (93% vs 66%; P = .05) were positively associated with routine neonatal immunization before July 1999. Both academic affiliation and city location were associated with routine immunization in August 2000 (71% vs 25% [P = .003] and 60% vs 14% [P = .002], respectively) and with compliance with recommendations for suspension (57% vs 25% [P = .03] and 56% vs 10% [P = .001]).
Conclusions We documented a 35% decrease in hospital nurseries that routinely offered HBV immunization 1 year after the AAP and PHS recommendations were made. Special efforts may be required to make at-birth administration of HBV vaccination universal.
Author Affiliations: Pediatric Immunization Program and Departments of Pediatrics (Drs Oram and Daum and Mr Seal) and Health Studies (Dr Lauderdale), the University of Chicago, Chicago, Ill.
RELATED LETTER
Hepatitis B Vaccination for Newborns
Erdem I. Cantekin, Michael Belkin, Ronda J. Oram, Diane S. Lauderdale, John B. Seal, and Robert S. Daum
JAMA. 2001;286(5):535-536.
EXTRACT
| FULL TEXT
RELATED ARTICLE
April 11, 2001
JAMA. 2001;285(14):1903-1904.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Impact of the 2004 Influenza Vaccine Shortage on Repeat Immunization Rates
Schade and Hannah
Ann Fam Med 2006;4:541-547.
ABSTRACT
| FULL TEXT
The Immunologic Basis for Neonatal Immunizations
Baley and Leonard
NeoReviews 2005;6:e463-e470.
FULL TEXT
Assessment of Perinatal Hepatitis B and Rubella Prevention in New Hampshire Delivery Hospitals
Bascom et al.
Pediatrics 2005;115:e594-e599.
ABSTRACT
| FULL TEXT
Pediatricians' Self-reported Clinical Practices and Adherence to National Immunization Guidelines After the Introduction of Pneumococcal Conjugate Vaccine
Lee et al.
Arch Pediatr Adolesc Med 2004;158:695-701.
ABSTRACT
| FULL TEXT
Impact of Thimerosal-Related Changes in Hepatitis B Vaccine Birth-Dose Recommendations on Childhood Vaccination Coverage
Luman et al.
JAMA 2004;291:2351-2358.
ABSTRACT
| FULL TEXT
Impact of the Thimerosal Controversy on Hepatitis B Vaccine Coverage of Infants Born to Women of Unknown Hepatitis B Surface Antigen Status in Michigan
Biroscak et al.
Pediatrics 2003;111:e645-649.
ABSTRACT
| FULL TEXT
Reasons Hospitals Give for Not Offering Hepatitis B Vaccine to Low-Risk Newborns
Aiken et al.
CLIN PEDIATR 2002;41:681-686.
ABSTRACT
Hepatitis B Vaccination for Newborns
Cantekin et al.
JAMA 2001;286:535-536.
FULL TEXT
AAP News 2001;18:246-246.
FULL TEXT
|
